2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Supranuclear Palsy, Progressive: new trials by email Literature Review of Supranuclear Palsy, Progressive trials Research Report on Supranuclear Palsy, Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Parkinson's And Zoledronic Acid Zoledronic Acid 5Mg/Bag 100Ml Inj, Placebo - Parkinson Disease, Osteoporosis | Phase 4 | Completed | California Pacific Medical Center Research Institute | 2721 | 2019-11-15 | 2026-06-25 |
| Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP) Suvorexant, Zolpidem, Placebo oral capsule - Progressive Supranuclear Palsy(PSP), Insomnia | Phase 4 | Completed | University of California, San Francisco | 40 | 2019-06-02 | 2026-09-01 |
Fractures, Bone (1) · Lewy Body Disease (1) · Multiple System Atrophy (1) · Osteoporosis (1) · Parkinson Disease (1) · Parkinsonian Disorders (1) · Sleep Initiation and Maintenance Disorders (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cranial Nerve Diseases (2) · Eye Diseases (2) · Mental Disorders (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Ocular Motility Disorders (2) · Ophthalmoplegia (2) · Paralysis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Zoledronic Acid (1) · Zolpidem (1) · suvorexant (1)
California Pacific Medical Center Research Institute (1) · University of California, San Francisco (1)
United States (2)
Steve Cummings, MD (1) · Thomas Neylan, MD (1)
R01AG059417 (1)